Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-02 @ 8:48 AM
Study NCT ID:
NCT04949503
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2021-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN
Sponsor:
Biotech Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BPL-Nimo-SCCHN-RWS-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None